Turkish Journal of Medical Sciences
Volume 51

Number 2

Article 2

1-1-2021

Vertebral compression fractures: Still an unpredictable aspect of
osteoporosis
FATMA YEŞİM KUTSAL
GİZEM OLGU ERGİN ERGANİ

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KUTSAL, FATMA YEŞİM and ERGANİ, GİZEM OLGU ERGİN (2021) "Vertebral compression fractures: Still
an unpredictable aspect of osteoporosis," Turkish Journal of Medical Sciences: Vol. 51: No. 2, Article 2.
https://doi.org/10.3906/sag-2005-315
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss2/2

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Medical Sciences
http://journals.tubitak.gov.tr/medical/

Review Article

Turk J Med Sci
(2021) 51: 393-399
© TÜBİTAK
doi:10.3906/sag-2005-315

Vertebral compression fractures: Still an unpredictable aspect of osteoporosis
Fatma Yeşim KUTSAL*, Gizem Olgu ERGİN ERGANİ
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Received: 24.05.2020

Accepted/Published Online: 24.09.2020

Final Version: 30.04.2021

Abstract: Vertebral compression fracture is a hallmark of osteoporosis (OP) and by far the most prevalent fragility fracture. It is well
proven that patients who develop a vertebral compression fracture are at substantial risk for additional fractures. Diagnosis is based on
adequate clinical evaluation, imaging, and laboratory tests. The imaging of OP and fragility fractures includes conventional radiology to
evaluate spinal fractures, bone mineral density (BMD) testing by dual energy x-ray densitometry, quantitative computerized tomography,
magnetic resonance imaging, bone scintigraphy (if necessary), and ultrasound. Screening and treatment of individuals with high risk of
osteoporotic fracture are cost-effective, but approximately two-thirds of the vertebral compression fractures (VCF) that occur each year
are not accurately diagnosed and, therefore, not treated. Evaluation of VCFs, even though they may be asymptomatic, seems essential to
health-related and/or clinical research on OP.
Key words: Osteoporosis, spine, spinal fractures, bone density

1. Introduction
Osteoporosis (OP) is one of the most frequent metabolic
bone disorders worldwide. It has been defined as a
skeletal disorder characterized by compromised bone
strength, predisposing a person to increased risk of
fracture. OP is a silent disorder that does not display any
evidence of disease until a fracture occurs. The health
consequences of osteoporotic fractures not only have a
negative impact on the quality of life but cause disability,
as well. A vertebral compression fracture (VCF) is by far
the most prevalent fragility fracture and is a hallmark of
OP. It has been proven that patients who already have
a VCF are at substantial risk for additional fractures
[1–3]. One can say that VCF status is a powerful
and independent risk factor for all new osteoporotic
fractures, which is a major health care problem in the
aging population since the incidence of these fractures
increases with age [4].
Independently of bone mineral density (BMD)
measurements, the prevalence and severity of VCFs
have been shown to be predictive for the risk of new
osteoporotic fractures [5].
If a VCF exists, the focus shifts to rehabilitation
and prevention of the next fracture. These fractures
can be linked with various problems such as back pain,
sleeping problems, decreased activity, more bone loss,
increased fracture risk, spinal deformity, decreased lung

capacity, impaired function, increased comorbidities,
and eventually mortality [6].
Although the concept of risk factor evaluation is
gaining ground, the current clinical practice of OP
assessment is still largely based on the evaluation of
BMD. This is the main reason why most patients with
VCFs are not clinically recognized. Additional imaging
studies of the spine have not become routine for several
reasons, including lack of awareness of VCF status as
an independent risk factor and possibly because OP is
a disease secondary to many other health problems; it
is also not the “core” expertise of many physicians [7].
2. Epidemiology
A diagnosis of OP or previous fragility fracture was
reported in around one-third of patients by Ong et al.
Most patients (75% male and 78% female) had 5 or more
copathologies, and many of them were more dependent
on activities of daily living on discharge compared to their
preadmission level [8]. The incidence of new VCFs in
females and males aged 50 years and over was 10.7/1000
people and 5.7/1000 people, respectively; the prevalence
increased from 3% in females under 60 years of age to 20%
in females over 70 years old and from 7.5 to 20% in males
over the same age range [9].
Epidemiologic data related to osteoporotic fractures
are limited in Turkey. In a retrospective chart review
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of 934 osteoporotic women, the aim was to explore
the frequency of osteoporotic fractures in osteoporotic
women on the basis of an outpatient clinic data and define
the relationship between osteoporotic fractures and age,
menopause status, BMD, and body mass index (BMI).
Osteoporotic fractures were observed in 194 patients
(20.8%). Vertebral compression fractures were the most
common form of osteoporotic fracture (107 patients).
The authors stated that there was no significant difference
in terms of BMI between the patients with or without
fractures [10].
As a matter of fact, most of the men with OP and
osteoporotic fractures are not diagnosed and do not receive
treatment. A crosssectional study included 2 groups of
male patients: a total of 71 nursing home residents with
a mean age of 76.0 years (nursing home group) and 44
men living in their homes with a mean age of 74.4 years
(control group). BMD measurements were performed in
all subjects, and the Spinal Deformity Index and Fracture
Risk Assessment Tool were also used. OP was detected in
25.3% of patients in the nursing home group and 8.8%
of patients in the control group. The authors stated that
silent VCF was present in 27.8% of males older than 65
years. The VCF rate was higher in nursing home residents
(42.2%) than in the control group (17.6%); in addition,
male nursing home residents seemed at a higher risk
for both OP and VCF. Results also showed that 5.6% of
patients in the nursing home group and 8.9% of those in
the male control group were aware of their VCFs [11].
3. Clinical manifestations
VCF is defined as a decrease of at least 15% to 20% in
height of the vertebra. These fractures can occur anywhere
in the spine, most commonly in the lower thoracic spine
and due to minor activity such as coughing or getting in
or out of the bathtub (for people with advanced OP). The
majority of the compressive damage is limited to the front
of the vertebral column, and the fracture is usually stable,
so it can be rarely associated with nerve root irritation or
spinal cord damage [8].
It is difficult to determine the cause and the exact
time of fragility fractures of the vertebral body, and they
often go undiagnosed. During evaluation of the patient,
there are some clinical history details that can suggest a
possible VCF. These include: (i) recent direct or indirect
trauma, (ii) age, (iii) prolonged use of glucocorticoids,
(iv) structural spinal deformity, and (v) loss of height >
6 cm. Therefore, it is strongly recommended to carefully
evaluate the presence of dorsolumbar pain, progressive
loss of height, or dorsal kyphosis. Multiple VCFs may
result in alterations of some system functions, mainly
pulmonary or gastrointestinal [12].
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3.1. Symptomatology
The basic symptoms of a VCF are a sudden onset of back
pain, which gets worse by standing or walking. Lying on
one’s back makes the pain less intense. This is followed
by limited spinal mobility, height loss, deformity, and
disability. Some patients with VCFs report that they
feel no back pain or other symptoms. Even if there is no
back pain, middle-aged or elderly individuals (especially
women) need to be concerned about potential fractures
if there is evidence of any of the following: height loss,
limited ability to twist and bend the back, or deformity that
develops in the spine. The pain from an osteoporotic VCF
typically lasts about 4 to 6 weeks as the bone heals. Some
patients have reported that the more severe pain subsides
and turns into more of a chronic, achy pain concentrated
in the area of the back where the fracture occurred. This is
because of the ligament problems due to postural changes.
Musculoskeletal pain is common in elderly people, and
clinical or subclinical VCFs are common causes. This pain
may eventually result in functional and psychological
impairments.
Thorough physical examination is
important in revealing the underlying cause of “pain.”
[6,13]
To identify individuals with asymptomatic VCFs,
several clinical thresholds for height loss have been
proposed. A 15° increase in kyphosis is associated
with the presence of a VCF, but an adjustment for age
should be done. Also, clinicians should keep in mind
that it is important to demonstrate whether simple selfreported kyphosis is associated with the presence of VCFs
determined by lateral radiographs since it is likely that
patients with undiagnosed VCFs may feel the presence of
kyphosis themselves. A crosssectional survey that aimed
to clarify the associations of self-reported height loss and
kyphosis with VCFs enrolled 407 women aged 60–92 years
old who visited an orthopedic clinic in Japan. Kamimura
et al. noted that both self-reported kyphosis and height
loss were significantly associated with the presence and
number of VCFs. As a result, these simple self-reports
may be a useful tool for identifying undetected VCFs [3].
3.2. Impact on quality of life
Physical, emotional, and psychological incapacity,
combined with the pain that results from hip, spine, or
wrist fractures, can alter quality of life (QoL). QoL in men
and women with OP should be thoroughly investigated,
even prior to the occurrence of a fracture to develop
appropriate interventions that can empower patients
to effectively manage all stages of the disease [14,15]. It
has been reported that VCFs have a negative impact on
QoL, and their presence is linked with cardiopulmonary
morbidities, depression, and death [6].
Numerous studies have documented the detrimental
effect of fragility fractures on the health-related QoL
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(HRQoL) of individuals with OP [16,17]. In addition,
researchers have agreed that an important marker of the
clinical evolution of patients with OP and fractures is the
assessment of HRQoL. Not only the fragility fractures
but physical, emotional, and psychological incapacity can
alter QoL [18–20].
A population-based crosssectional study which aimed
to examine the association between prevalent VCF and
back pain, neck pain, and HRQoL in elderly women and
men, and which looked at possible sex-related differences
in reported pain and HRQoL, included a total of 2887
individuals (1681 of whom were women) at a mean age
of 65.4 years old. The study showed that prevalent VCF is
associated with an increased risk of back pain and reduced
HRQoL in postmenopausal women but not in men [21].
According to Salaffi et al., HRQoL scores were lower in
women with lumbar VCFs compared with women with
thoracic VCFs, only when the physical functioning and
bodily pain dimensions approached statistical significance
[22]. The number of VCFs was shown to be a determinant
of a low QoL. As VCFs are usually asymptomatic and
associated with reduced QoL, increased morbidity and
mortality and an increased risk of future vertebral and
nonvertebral fractures, detection remains an important
challenge for clinicians [23].
4. Diagnostic approach
According to the literature, as many as one-third
of all VCFs are never clinically diagnosed, mainly
because of methodological problems. VCFs may also be
asymptomatic, but it has been documented in several
studies that osteoporotic VCFs may be associated with
acute/chronic back pain [21]. The first step in the diagnosis
is based on risk assesment.
4.1. Assessments of risks
Assessments of VCF risks are based not only on physical
examination but also on a complete case history,
laboratory, and diagnostic imaging tests. Complete
case histories require additional information related to
patients’ medical histories (especially the presence of
comorbidities, any medication that may interfere with
bone metabolism, previous fragility fractures, family
history of fractures, gynecological history and age at
the onset of menopause (in women)), lifestyle, and an
evaluation of personal and environmental risk factors.
According to the “guidelines for the management of OP
and fragility fractures,” evaluation of the patient’s posture
is mandatory, especially if there is an increase in kyphosis
or height loss, which may indicate the presence of one or
more VCFs [12].
Fracture risk assessment tool-FRAX can be used in
clinical practice. This is a computer-based algorithm
that permits the classification of risk. It has been

documented that WHO FRAX algorithms have facilitated
the assessment of fracture risk on the basis of fracture
probability [24].
Diagnosis is based on adequate clinical evaluation,
imaging, and laboratory tests; the accurate diagnosis
of VCF is important for the treatment of OP and for
the prevention of new fractures. Since many VCFs
are asymptomatic or cause mild pain, the majority of
VCFs are not diagnosed worldwide. Only 1 in 3 VCFs is
clinically diagnosed and, according to the available data,
the majority of cases are either undetected or incidentally
detected by radiographic testing.
Diagnostic imaging of OP and of fragility fractures
includes basic conventional radiology to evaluate spinal
fractures, BMD testing by DXA, quantitative computerized
tomography (QCT), magnetic resonance imaging (MRI),
bone scintigraphy (if necessary), and ultrasound (QUS).
QCT, MRI, and bone scintigraphy are used for differential
diagnosis. In symptomatic osteoporotic patients, bone
scintigraphy can be helpful in elucidating the etiology
of back pain. If central DXA is unavailable, QUS can be
used to identify subjects at low or high risk of osteoporotic
fracture.
In spite of the fact that the BMD assay is considered the
best predictor of osteoporotic fragility fracture risks, it is
always recommended that an adequate clinical evaluation
be performed [12].
Jager et al. showed that combined vertebral fracture
assessment (VFA) and the BMD method detect previously
unknown VCFs in nearly 1 out of every 6 patients with a
significant impact on management [7].
4.2. Radiology
VCFs need radiological confirmation (the semiquantitative
method of Genant with conventional spine radiography is
traditionally used in the evaluation of VCFs) but are often
undiagnosed by radiologists, with a misdiagnosis rate of
up to 50% [9]. The reasons for this inadequacy are the
following: VCFs frequently do not present as a clinically
recognizable event and many radiologically apparent
VCFs go unreported [25,26].
4.3. Indications for vertebral radiographs
In a clinical practice guideline, Camacho et al. stated
that if prevalent VCFs could alter clinical management
for patients with unexplained height loss or back pain,
thoracic and lumbar spine radiography or VFA by
DXA is indicated. The sensitivity for detecting prevalent
VCFs seems low, but these height loss thresholds have
>90% specificity. Also, if there is kyphosis or systemic
glucocorticoid therapy, vertebral radiographs are
indicated [27].
4.4. Reporting vertebral fractures
When reporting VCFs, radiologists and clinicians
should avoid using ambiguous terms such as “collapse,”
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“compression,” “loss of height,” “wedging,” or “wedge
deformity.” Instead, the terms “mild,” “moderate,” or
“severe” to describe VCFs are recommended [25,26].
Radiographic studies have identified 3 types of VCFs:
wedging (anterior), biconcavity (middle), and a total
collapse of vertebra. These definitions depend on the type
and severity of the spinal height reduction. For a more
accurate identification, there are also 2 other methods. The
first is the semiquantitative visual method, which is based on
an initial phase of visual evaluation of images for differential
diagnosis. This gradation of osteoporotic VCFs is called
the Genant criteria and is classified as mild, moderate, or
severe. The second one is the quantitative morphometric
method, which is performed by conventional radiology or
with DXA, using VFA software by lower radiation doses in
a single image. The VFA technique is applied to assess the
severity of the VCFs or to pinpoint a possible worsening of
preexisting VCFs during follow-up [12].
4.5. Vertebral fracture assessment
Population-based assessment of VCFs can be carried
out by common DXA densitometers. This method is
VFA and has been used in many population settings.
According to Waterloo et al., its sensitivity and specificity
are comparable to vertebral radiographs in their ability to
diagnose grade 2 (moderate) and grade 3 (severe) VCFs
[21]. The VFA technique enables the acquisition of a
patient-friendly alternative to conventional radiographs
(with lower radiation exposure and relatively lower costs)
for the assessment of VCFs in a one-stop diagnostic test.
However, Malgo et al. stated that the advantage of lowerradiation doses used in certain BMD scanners can be
associated with the drawback of poor image quality, which
could lead to misclassification of VCFs for the ascertaining
of a vertebra as nonevaluable, leading to an inaccurate
estimation of fracture risk [5].
Considering the fact that that most osteoporotic VCFs
are asymptomatic, it is difficult to identify symptomatic
VCFs, especially in patients with concomitant fractures.
Concomitant acute osteoporotic VCFs and previous VCFs
are common and are often overlooked. Risk factors for the
occurrence of concomitant acute osteoporotic VCFs are:
a low T-score in DXA and the number of previous VCFs.
Performing an MRI scan of the thoracic and lumbar spine
with STIR and T1w sequences in patients with multiple
acute osteoporotic VCFs or suspicion of concomitant
acute osteoporotic VCFs can be useful in order to detect all
acute concomitant VCFs and start adequate and effective
fracture treatment [28].
5. Prevention and treatment
5.1. Fracture prevention
There are a number of unmet needs when assessing OP and
a number of strategies to prevent the continual increase
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of the disease. These are: (i) optimizing peak bone mass
in young adults, (ii) structural implementation of a fourstep diagnostic procedure in patients with clinical risk
factors for osteoporotic fractures: DXA, VFA, fall risk, and
secondary OP, (iii) more adequate measurement of bone
strength, (iv) reduction in the treatment gap, (v) new drugs
with a better efficacy/safety profile, (vi) shared decisionmaking with optimal nonmedical and medical treatment
(nonpharmacological interventions include specific
physical exercises for OP to improve muscle strength and
balance, decrease pain, and improve QoL), and (vii) new
strategies such as treat to target and definition of high-risk
patients [29].
Unfortunately, fracture prevention is suboptimal
and the reasons are: (i) fractures do occur, mainly in
the elderly, (ii) fear of severe side effects, (iii) lack of
education in professionals and in the lay public, (iv) lack
of engagement: OP is a low medical priority, (v) lack of
coordination between health care systems, (vi) inadequate
access to diagnostics such as BMD measurement and
VFA, (vii) suboptimal predictive value of diagnostic
techniques, (viii) the treatment gap, (ix) low adherence
and compliance to antiosteoporotic drugs, (x) generic
drugs, the nocebo-effect (negative counterpart); and (xi)
lack of focus on muscle strength and fall prevention [29].
5.2. Treatment
Approximately two-thirds of the VCFs that occur each
year are not accurately diagnosed and, therefore, not
treated. The patients’ pain is often just thought of as back
pain, resulting from “soft tissue injuries” or “spondylosis”
or as a “common part of aging.” It should be kept in mind
that despite the absence of VCFs, “bone resorption” due to
OP may also cause back pain [6,13].
Since standardized and accepted treatment evidencebased concepts are missing for certain fracture types, the
treatment of osteoporotic VCFs is widely empirical. As in
other osteoporotic fractures in the elderly, the key for a
good outcome may be a combination of interdisciplinary
treatment approaches and adapted surgical procedures
[30].
The basic treatment of vertebral fractures in the acute
stage involves conservative measures such as bed rest,
minor and major analgesic medications, physical therapy,
and bracing.
For all patients, optimizing vitamin D and calcium
status, as well as recommendation of risk appropriate
exercises and fall prevention stategies, are mandatory.
According to the latest treatment algorithm published by
Kanis et al., in addition to the categories of low and high
risk espoused in the current IOF-ESCEO guideline, a very
high-risk status can also be identified and is defined as a
fracture probability that lies above the upper assessment
threshold after a FRAX assessment. For women at high
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risk, treatment usually starts with an antiresorptive drug,
while patients at very high risk usually need anabolic
therapy followed by antiresorptive drugs [31].
In a recent clinical practice guideline, 4 principles were
published for the management of OP and osteoporotic
fractures: (i) country-specific assessment tools should
be used to identify possible fracture risk, (ii) patient
preferences should be included in treatment plans, (iii)
all pharmacological treatments should be accompanied
by nutritional and lifestyle changes and strategies for
prevention of falls, and (iv) in postmenopausal women who
are at risk, pharmacological treatments can reduce fracture
rates with acceptable risk-benefit and safety profiles [32].
Pain due to vertebral fracture often lasts for 1–3 weeks
and then begins to subside and disappears within a few
months. However, in some cases, a biomechanical instability
may develop and persist due to the severity and location of
the VCF. Vertebroplasty or kyphoplasty may therefore be
considered in patients with intractable pain. Potential risks
associated with these procedures and uncertain benefits
over the long term should be considered in these practices,
and these interventions are not found to be suitable
in patients with no symptoms or mild symptoms [12].
It is well known that in VCFs, the primary goal of the
surgical approach is to stabilize the spinal column and
correct the deformity. In order to guide clinical practice,
several symptoms have been identified that are thought to
be relatively specific indications for further investigation.
This further examination is often reported to be MRI
because it is the most preferred diagnostic modality.
Vertebral augmentation has been recommended in
patients with positive imaging results and also worsening
of the symptoms (e.g., decreased vertebral heights,
negative impacts on functioning, etc.) [33]. Nevertheless,
regarding the role of kyphoplasty and vertebroplasty
interventions, no definitive consensus has been reached.

Also, no conclusions can be drawn about the superiority of
cementoplasty techniques over conservative management,
according to Longo et al [34].
6. Conclusion
It has been stated that the huge burden caused by OPrelated fractures to individuals, healthcare systems,
and societies should provide a clear impetus for the
progression of such approaches [35]. The cost of these
fractures is enormous and is forecast to steadily increase
globally over the coming decades. Low BMD remains a
key preventable risk factor for fractures. Screening and
treatment of individuals with a high risk of fracture is costeffective. Predictive tools including “clinical risk factors,”
“minimization of falls risk,” and “public authorities’
support” to create Fracture Liaison Services are suggested
as paramount strategies [36].
There is strong evidence and consensus about the
disease and its complications, but physicians still do not
put enough effort in the identification and prevention of
osteoporotic VCFs. Evaluation of the VCFs, even though
they may be asymptomatic, seems essential to health related
and/or clinical researches on OP. It has been suggested
that physicians should give much more attention to their
research efforts in increasing the awareness of not only the
clinicians but the public, as well. Recommendations for
primary screening are being developed to reduce mortality
and morbidity caused by fragility fractures [37]. These
practices, which are becoming increasingly important
in terms of the health policies of countries, should be
reviewed not only from the vantage point of health but
also in terms of social, psychological, and economical
perspectives.
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